107 related articles for article (PubMed ID: 33632900)
1. Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification.
Alay A; Cordero D; Hijazo-Pechero S; Aliagas E; Lopez-Doriga A; Marín R; Palmero R; Llatjós R; Escobar I; Ramos R; Padrones S; Moreno V; Nadal E; Solé X
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33632900
[TBL] [Abstract][Full Text] [Related]
2. BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma.
Xu D; Gao Y; Yang H; Spils M; Marti TM; Losmanová T; Su M; Wang W; Zhou Q; Dorn P; Shu Y; Peng RW
JTO Clin Res Rep; 2024 May; 5(5):100672. PubMed ID: 38715965
[TBL] [Abstract][Full Text] [Related]
3. CHST4 Gene as a Potential Predictor of Clinical Outcome in Malignant Pleural Mesothelioma.
Okado S; Kato T; Hanamatsu Y; Emoto R; Imamura Y; Watanabe H; Kawasumi Y; Kadomatsu Y; Ueno H; Nakamura S; Mizuno T; Takeuchi T; Matsui S; Chen-Yoshikawa TF
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396947
[TBL] [Abstract][Full Text] [Related]
4. Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Nastase A; Mandal A; Lu SK; Anbunathan H; Morris-Rosendahl D; Zhang YZ; Sun XM; Gennatas S; Rintoul RC; Edwards M; Bowman A; Chernova T; Benepal T; Lim E; Taylor AN; Nicholson AG; Popat S; Willis AE; MacFarlane M; Lathrop M; Bowcock AM; Moffatt MF; Cookson WOCM
Sci Rep; 2021 Sep; 11(1):19138. PubMed ID: 34580349
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.
Chen R; Lee WC; Fujimoto J; Li J; Hu X; Mehran R; Rice D; Swisher SG; Sepesi B; Tran HT; Chow CW; Little LD; Gumbs C; Haymaker C; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Zhang J; Reuben A; Tsao AS; Zhang J
Clin Cancer Res; 2020 Oct; 26(20):5477-5486. PubMed ID: 32816946
[TBL] [Abstract][Full Text] [Related]
6. The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review.
Désage AL; Karpathiou G; Peoc'h M; Froudarakis ME
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206956
[TBL] [Abstract][Full Text] [Related]
7. Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma.
Lin Y; Burt BM; Lee HS; Nguyen TT; Jang HJ; Lee C; Hong W; Ripley RT; Amos CI; Cheng C
NPJ Precis Oncol; 2024 Feb; 8(1):47. PubMed ID: 38396241
[TBL] [Abstract][Full Text] [Related]
8. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
Hiltbrunner S; Mannarino L; Kirschner MB; Opitz I; Rigutto A; Laure A; Lia M; Nozza P; Maconi A; Marchini S; D'Incalci M; Curioni-Fontecedro A; Grosso F
Front Oncol; 2021; 11():660039. PubMed ID: 34249695
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma.
Yang H; Xu D; Yang Z; Yao F; Zhao H; Schmid RA; Peng RW
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824422
[No Abstract] [Full Text] [Related]
10. Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hopper MA; Wenzl K; Hartert KT; Krull JE; Dropik AR; Novak JP; Manske MK; Serres MR; Sarangi V; Larson MC; Maurer MJ; Yang ZZ; Paludo J; McPhail ED; Habermann TM; Link BK; Rimsza LM; Ansell SM; Cerhan JR; Jevremovic D; Novak AJ
Hematol Oncol; 2023 Oct; 41(4):644-654. PubMed ID: 37254453
[TBL] [Abstract][Full Text] [Related]
11. How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers.
Behrouzfar K; Burton K; Mutsaers SE; Morahan G; Lake RA; Fisher SA
Front Oncol; 2021; 11():679609. PubMed ID: 34235080
[TBL] [Abstract][Full Text] [Related]
12. Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation.
Godec J; Tan Y; Liberzon A; Tamayo P; Bhattacharya S; Butte AJ; Mesirov JP; Haining WN
Immunity; 2016 Jan; 44(1):194-206. PubMed ID: 26795250
[TBL] [Abstract][Full Text] [Related]
13. A functional module states framework reveals transcriptional states for drug and target prediction.
Qin G; Knijnenburg TA; Gibbs DL; Moser R; Monnat RJ; Kemp CJ; Shmulevich I
Cell Rep; 2022 Jan; 38(3):110269. PubMed ID: 35045296
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Guzmán-Casta J; Carrasco-CaraChards S; Guzmán-Huesca J; Sánchez-Ríos CP; Riera-Sala R; Martínez-Herrera JF; Peña-Mirabal ES; Bonilla-Molina D; Alatorre-Alexander JA; Martínez-Barrera LM; Rodríguez-Cid JR
Thorac Cancer; 2021 Apr; 12(7):1014-1022. PubMed ID: 33660947
[TBL] [Abstract][Full Text] [Related]
15. Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.
Alemany M; Domènech M; Argyriou AA; Vilariño N; Majós C; Naval-Baudin P; Lucas A; Palmero R; Simó M; Nadal E; Bruna J
Ann Transl Med; 2021 Apr; 9(8):648. PubMed ID: 33987346
[TBL] [Abstract][Full Text] [Related]
16. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J
JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308
[TBL] [Abstract][Full Text] [Related]
17.
Brown LC; Tucker MD; Sedhom R; Schwartz EB; Zhu J; Kao C; Labriola MK; Gupta RT; Marin D; Wu Y; Gupta S; Zhang T; Harrison MR; George DJ; Alva A; Antonarakis ES; Armstrong AJ
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653800
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer.
Hijazo-Pechero S; Alay A; Marín R; Vilariño N; Muñoz-Pinedo C; Villanueva A; Santamaría D; Nadal E; Solé X
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638221
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.
Aliagas E; Alay A; Martínez-Iniesta M; Hernández-Madrigal M; Cordero D; Gausachs M; Pros E; Saigí M; Busacca S; Sharkley AJ; Dawson A; Palmero R; Ruffinelli JC; Padrones S; Aso S; Escobar I; Ramos R; Llatjós R; Vidal A; Dorca E; Varela M; Sánchez-Céspedes M; Fennell D; Muñoz-Pinedo C; Villanueva A; Solé X; Nadal E
Br J Cancer; 2021 Nov; 125(10):1365-1376. PubMed ID: 34588615
[TBL] [Abstract][Full Text] [Related]
20. Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Zhang M; Luo JL; Sun Q; Harber J; Dawson AG; Nakas A; Busacca S; Sharkey AJ; Waller D; Sheaff MT; Richards C; Wells-Jordan P; Gaba A; Poile C; Baitei EY; Bzura A; Dzialo J; Jama M; Le Quesne J; Bajaj A; Martinson L; Shaw JA; Pritchard C; Kamata T; Kuse N; Brannan L; De Philip Zhang P; Yang H; Griffiths G; Wilson G; Swanton C; Dudbridge F; Hollox EJ; Fennell DA
Nat Commun; 2021 Mar; 12(1):1751. PubMed ID: 33741915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
